Dumas, Pierre-Yves http://orcid.org/0000-0003-0119-3548
Raffoux, Emmanuel
Bérard, Emilie
Bertoli, Sarah http://orcid.org/0000-0003-1084-2781
Hospital, Marie-Anne
Heiblig, Maël http://orcid.org/0000-0003-1682-8657
Desbrosses, Yohann
Bonmati, Caroline
Pautas, Cécile
Lambert, Juliette http://orcid.org/0000-0001-5142-0310
Orvain, Corentin http://orcid.org/0000-0002-8717-0824
Banos, Anne
Pasquier, Florence
Peterlin, Pierre
Marchand, Tony http://orcid.org/0000-0003-4932-2169
Uzunov, Madalina
Frayfer, Jamilé
Turlure, Pascal
Cluzeau, Thomas http://orcid.org/0000-0002-6745-1127
Jourdan, Eric
Himberlin, Chantal
Tavernier, Emmanuelle
Villate, Alban
Haiat, Stephanie
Chretien, Marie-Lorraine
Carre, Martin
Chantepie, Sylvain
Vaida, Ioana
Wemeau, Mathieu
Chebrek, Safia
Guillerm, Gaelle
Guièze, Romain
Debarri, Houria
Gehlkopf, Eve
Laribi, Kamel
Marcais, Ambroise http://orcid.org/0000-0002-6844-7920
Santagostino, Alberto
Béné, Marie-Christine http://orcid.org/0000-0002-6569-7414
Mineur, Ariane
Pigneux, Arnaud
Dombret, Hervé
Récher, Christian http://orcid.org/0000-0002-3332-4525
Article History
Received: 25 July 2022
Revised: 12 October 2022
Accepted: 20 October 2022
First Online: 14 November 2022
Competing interests
: Pierre-Yves Dumas: Daiichi-Sankyo, Jazz Pharmaceutical, Astellas, Abbvie, Celgene, Janssen. Emmanuel Raffoux: Daiichi-Sankyo, Astellas, Abbvie, Celgene, Pfizer. Emilie Berard: no competing interest. Sarah Bertoli: Jazz Pharmaceuticals, Daiichi-Sankyo, Sanofi, Astellas and BMS. Marie-Anne Hospital: no competing interest. Maël Heiblig: Astellas, Pfizer, Abbvie, Jazz Pharmaceuticals, Servier. Yohann Desbrosses: Jazz Pharmaceuticals, Abbvie, Celgene, Novartis. Caroline Bonmati: no competing interest. Cécile Pautas: Abbvie, BMS. Juliette Lambert: Pfizer, Astellas, Abbvie. Corentin Orvain: Novartis. Anne Banos: no competing interest. Florence Pasquier: no competing interest. Pierre Peterlin: Daiichi-Sankyo, Jazz Pharmaceutical, Astellas, Abbvie, BMS. Tony Marchand: Jazz Pharmaceutical, Servier. Madalina Uzunov: no competing interest. Jamilé Frayfer: no competing interest. Pascal Turlure: Daiichi-Sankyo. Thomas Cluzeau: Astellas, Novartis and institution: Novartis, Astellas, Arog. Eric Jourdan: Novartis, Abbvie, BMS. Chantal Himberlin: no competing interest. Emmanuelle Tavernier: Abbvie, BMS. Alban Villate: no competing interest. Stephanie Haiat: no competing interest. Marie-Lorraine Chretien: no competing interest. Martin Carre: Astellas, BMS, Jazz pharmaceutical. Sylvain Chantepie: no competing interest. Ioana Vaida: no competing interest. Mathieu Wemeau: Abbvie, AOP Orphan, BMS, Gilead, Novartis. Safia Chebrek: no competing interest. Gaelle Guillerm: no competing interest. Romain Guièze: Abbvie, Janssen, Beigene, Astrazeneca, Roche, Amgen.. Houria Debarri: no competing interest. Eve Gehlkopf: no competing interest. Kamel Laribi: Outside this work, KL received Grants from Novartis, Takeda, Jansen, Abbvie, and personal fees from Novartis, Takeda, Abbvie, Iqone, Astra Zeneca, and Beigene.. Ambroise Marcais: no competing interest. Alberto Santagostino: no competing interest. Marie-Christine Béné: no competing interest. Ariane Mineur: no competing interest. Arnaud Pigneux: Grant/Research Support: Astellas, Roche; Speaker’s Bureau: Astellas, AbbVie, Gilead, Pfizer, Roche, Sanofi; Consultant: Jazz, AbbVie, Agios, BMS, Gilead, Novartis, Pfizer, Roche, Takeda. Hervé Dombret: Honoraria/consulting: Abbvie, Amgen, Astellas, Celgene-BMS, Daiichi Sankyo, Incyte,. Jazz Pharmaceuticals, Pfizer, Servier; research funding: Amgen, Astellas, Celgene-BMS, Incyte, Jazz Pharmaceuticals, Pfizer. Christian Récher: Research grants from AbbVie, Amgen, Novartis, BMS-Celgene, Jazz Pharmaceuticals, Agios, Chugai, MaaT Pharma, Astellas, Roche, Daiichi-Sankyo and Iqvia; an advisory role for AbbVie, Janssen, Jazz Pharmaceuticals, Novartis, Celgene, Otsuka, Astellas, Daiichi-Sankyo, Macrogenics, Pfizer. Roche, Servier and Takeda.